UPB
Upstream Bio, Inc.
NASDAQ · USHealthcareBiotechnology
$6.98-0.43%
Price as of Jul 20, 2026
UPB valuation
Upstream Bio, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 157.06x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.25x
- Price / sales
- 114.34x
- Price / cash flow
- -2.71x
Enterprise value
- Enterprise value
- $86.4M
- EV / sales
- 26.00x
- EV / EBITDA
- -0.55x
- EV / EBIT
- -0.50x
- Market cap
- $379.9M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.